Immune activation status of CD8+T cells infiltrating non-small cell lung cancer

被引:42
|
作者
Trojan, A
Urosevic, M
Dummer, R
Giger, R
Weder, W
Stahel, RA
机构
[1] Univ Zurich Hosp, Dept Oncol, Dermatol Clin, CH-8091 Zurich, Switzerland
[2] Univ Zurich Hosp, Clin Thorac Surg, CH-8091 Zurich, Switzerland
关键词
non-small cell lung cancer (NSCLC); CD8+T cell; Interferon (IFN)-gamma-quantitative PCR;
D O I
10.1016/j.lungcan.2003.11.004
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In a variety of human cancers, the presence of tumor-infiltrating T lymphocytes (TILs) is associated with tumor regression and favorable prognosis. Local interferon (IFN)-gamma secretion from activated T cells is supposed to induce a specific immune response leading to tumor-specific cytotoxicity. Nonetheless, significance and properties of TILs still remains controversial in lung cancer patients. We determined CD8+ T cell counts in 31 patients with non-small cell lung cancer (NSCLC) by immunohistochemistry, and assessed T-cell immune activation status in a subset of patients by measuring IFN-gamma mRNA expression by quantitative PCR (TaqMan). Semi-quantitative immunohistochemical analysis revealed significantly higher CD8+ T cell counts within the tumor as when compared to the invasive margin. CD8+ T cells immune activation status, represented in the IFN-gamma/CD8 mRNA ratio, correlated with the median number of CD8+ T cells presented at the tumor-host interface. Neither tumor histology and grade, nor CD8+ T cell counts and IFN-gamma/CD8 ratio could demonstrate an influence on overall survival in these patients. Our results indicate that CD8+ T cells infiltrating the tumor cell nests may be inadequately activated and thus incapable of mounting an effective anti-tumor immune response. (C) 2003 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:143 / 147
页数:5
相关论文
共 50 条
  • [41] Characterization of γδ T cells in patients with non-small cell lung cancer
    Bao, Yi
    Guo, Li
    Mo, Juanfen
    [J]. ONCOLOGY LETTERS, 2017, 14 (01) : 1133 - 1140
  • [42] Imaging tumor-infiltrating CD8+ T-cells in non-small cell lung cancer patients upon neo-adjuvant treatment with durvalumab
    Aarntzen, E.
    Van Genugten, E. A. J.
    Piet, B.
    Schreibelt, G.
    Van Oorschot, T.
    Van den Heuvel, G.
    Ciompi, F.
    Jacobs, C.
    De Vries, J.
    Van den Heuvel, M. M.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2022, 49 (SUPPL 1) : S167 - S167
  • [43] Immune Signatures of Non-Small Cell Lung Cancer
    Green, Susan
    Dawe, David E.
    Banerji, Shantanu
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (06) : 913 - 915
  • [44] Menopausal status and non-small cell lung cancer
    Birdas, TJ
    [J]. ANNALS OF THORACIC SURGERY, 2005, 80 (02): : 789 - 790
  • [45] Importance of tumor infiltrating lymphocytes in non-small cell lung cancer?
    Bremnes, Roy M.
    Donnem, Tom
    Busund, Lill-Tove
    [J]. ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (07)
  • [46] Effect of smoking on tumor-infiltrating immune cell composition and prognosis in non-small cell lung cancer
    Tamminga, Menno
    Hiltermann, T. Jeroen N.
    Schuuring, Ed
    Fehrmann, Rudolf S.
    Groen, Harry J.
    [J]. CANCER RESEARCH, 2017, 77
  • [47] Prognostic effect of tumor-infiltrating immune cell composition in non-small cell lung cancer by histology
    Tamminga, Menno
    Hiltermann, T. Jeroen
    Schuuring, Ed
    Fehrmann, Rudolf S.
    Groen, Harry J.
    [J]. CANCER RESEARCH, 2017, 77
  • [48] TCF-1+ PD-1+ CD8+T cells are associated with the response to PD-1 blockade in non-small cell lung cancer patients
    Xia Fang
    Gang Wu
    Jing Hua
    Pei Zhao
    Mengtian Shan
    Na Wang
    Yu Zeng
    Tingting Ding
    Hailong Zhu
    Xuyou Zhu
    Long Zhang
    Yuting Liu
    Ling Zheng
    Xianghua Yi
    Shaoyong Gao
    [J]. Journal of Cancer Research and Clinical Oncology, 2022, 148 : 2653 - 2660
  • [49] Tumor infiltrating T cells influence prognosis in stage I-III non-small cell lung cancer
    Schulze, Arik Bernard
    Evers, Georg
    Goerlich, Dennis
    Mohr, Michael
    Marra, Alessandro
    Hillejan, Ludger
    Rehkaemper, Jan
    Schmidt, Lars Henning
    Heitkoetter, Birdie
    [J]. JOURNAL OF THORACIC DISEASE, 2020, 12 (05) : 1824 - +
  • [50] TCF-1+ PD-1+ CD8+T cells are associated with the response to PD-1 blockade in non-small cell lung cancer patients
    Fang, Xia
    Wu, Gang
    Hua, Jing
    Zhao, Pei
    Shan, Mengtian
    Wang, Na
    Zeng, Yu
    Ding, Tingting
    Zhu, Hailong
    Zhu, Xuyou
    Zhang, Long
    Liu, Yuting
    Zheng, Ling
    Yi, Xianghua
    Gao, Shaoyong
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (10) : 2653 - 2660